SIU School of Medicine

Jump directly to a section:

Office of Public Affairs

Portrait of John Godwin

November 4, 2011

Godwin Named ‘Top Doctor’ for 10th Consecutive Year

Dr. John Godwin, professor and chief of the hematology and oncology division in the  Department of Internal Medicine at Southern Illinois University School of Medicine in Springfield has been named one of America’s Top Doctors for the 10th consecutive year.  The award was issued by Castle Connolly Medical, Ltd. Godwin is also the associate director of Simmons Cancer Institute (SCI).

According to its website, Castle Connolly’s mission is to help consumers find the best health care.  The company surveys tens of thousands of physicians and hospital executives in order to identify, screen and select those physicians regarded by their peers as leaders in their specialties and for specific diseases and techniques.  The nominated physicians’ credentials are reviewed for medical education, training, hospital appointments, administrative posts, professional achievements, and malpractice and disciplinary history.

Dr. Godwin’s award “has been a result of Castle Connolly’s rigorous peer nominated, expert reviewed selection process.  Only a tiny percentage of physicians earn the prestigious recognition of America's Top Doctors. Even fewer have earned it 10 years in a row.  This truly indicates that Dr. Godwin is one of the best in his profession,” the notification read.

Godwin specializes in acute and chronic leukemias, lymphoma, myeloproliferative diseases, myelodysplastic syndrome (MDS), bleeding and clotting disorders, head and neck, and lung cancer.  He sees patients with head and neck, lung, and breast cancer care teams at SCI, as well as in the adult Hematology/Oncology clinic.  Godwin specializes in Phase II and III clinical trials in cancer.

He is a national principal investigator in clinical trials of acute myeloid leukemia and chronic lymphocytic leukemia.  He is a principal investigator in several clinical trials sponsored at SIU and Central Illinois Community Clinical Oncology Program (CICCOP).  He is also involved with national research on Cancer Control, including symptom control and quality of life, cancer survivors, health disparities, and molecular epidemiology of cancer.

The mission of the Simmons Cancer Institute at SIU is to serve the people of central and southern Illinois by addressing their present and future cancer care needs through education, research, patient care and community service.   Its website is